AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2019
May 17, 2019
31676_dirs_2019-05-17_192c84c2-4d00-4231-ba7c-7022d48e1b1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-05-16
Reporting Person: Brown Robert E. JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-16 | Common Stock | M | 1042 | $6.36 | Acquired | 21394 | Direct |
| 2019-05-16 | Common Stock | M | 1167 | $33.00 | Acquired | 22561 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-16 | Stock Option | $6.36 | M | 1042 | Disposed | 2023-07-11 | Common Stock (1042) | Direct |
| 2019-05-16 | Stock Option | $33.00 | M | 1167 | Disposed | 2024-03-31 | Common Stock (1167) | Direct |
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3